The Personalized Risk Interpretation Study (PRIS) is based on the idea that risk-based cancer screening seeks to maximize the benefits and minimize the harms of screening. To achieve these goals, cancer risk prediction models need to be translated into risk assessment tools that are meaningful and useful for the public and in clinical practice. However, a critical barrier to implementing risk-based screening is that many people are skeptical about how well their risk estimate actually reflects their true personal risk. Therefore, our goal is to understand the reasons for skepticism about personalized risk information, and to identify methods for communicating personalized risk information that people can both understand and accept.
This project is currently in progress. If you would like additional information about the study, please contact me at waterse@wustl.edu. We are currently seeking a research assistant for this project. For more details, click here.